BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16162663)

  • 1. Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation.
    van der Velden JL; Langen RC; Kelders MC; Wouters EF; Janssen-Heininger YM; Schols AM
    Am J Physiol Cell Physiol; 2006 Feb; 290(2):C453-62. PubMed ID: 16162663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
    Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
    Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myogenic differentiation during regrowth of atrophied skeletal muscle is associated with inactivation of GSK-3beta.
    van der Velden JL; Langen RC; Kelders MC; Willems J; Wouters EF; Janssen-Heininger YM; Schols AM
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1636-44. PubMed ID: 17166938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase 3 suppresses myogenic differentiation through negative regulation of NFATc3.
    van der Velden JLJ; Schols AMWJ; Willems J; Kelders MCJM; Langen RCJ
    J Biol Chem; 2008 Jan; 283(1):358-366. PubMed ID: 17977834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO1 and GSK-3β Are Main Targets of Insulin-Mediated Myogenesis in C2C12 Muscle Cells.
    Litwiniuk A; Pijet B; Pijet-Kucicka M; Gajewska M; Pająk B; Orzechowski A
    PLoS One; 2016; 11(1):e0146726. PubMed ID: 26785133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of glucocorticoids and IGF-1 on myogenic differentiation through the Akt/GSK-3β pathway in C2C12 myoblasts.
    Fang XB; Song ZB; Xie MS; Liu YM; Zhang WX
    Int J Neurosci; 2020 Nov; 130(11):1125-1135. PubMed ID: 32070170
    [No Abstract]   [Full Text] [Related]  

  • 7. Segregation of myoblast fusion and muscle-specific gene expression by distinct ligand-dependent inactivation of GSK-3β.
    Pansters NA; van der Velden JL; Kelders MC; Laeremans H; Schols AM; Langen RC
    Cell Mol Life Sci; 2011 Feb; 68(3):523-35. PubMed ID: 20694829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein breakdown in muscle from burned rats is blocked by insulin-like growth factor i and glycogen synthase kinase-3beta inhibitors.
    Fang CH; Li BG; James JH; King JK; Evenson AR; Warden GD; Hasselgren PO
    Endocrinology; 2005 Jul; 146(7):3141-9. PubMed ID: 15802492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glycogen synthase kinase-3β attenuates glucocorticoid-induced suppression of myogenic differentiation in vitro.
    Ma Z; Zhong Z; Zheng Z; Shi XM; Zhang W
    PLoS One; 2014; 9(8):e105528. PubMed ID: 25127359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSK-3beta negatively regulates skeletal myotube hypertrophy.
    Vyas DR; Spangenburg EE; Abraha TW; Childs TE; Booth FW
    Am J Physiol Cell Physiol; 2002 Aug; 283(2):C545-51. PubMed ID: 12107064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3beta is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1.
    Seimi SK; Seinosuke K; Tsuyoshi S; Tomomi U; Tetsuaki H; Miki K; Ryuji T; Kenji I; Mitsuhiro Y
    Circ J; 2004 Mar; 68(3):247-53. PubMed ID: 14993781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle.
    Pansters NA; Schols AM; Verhees KJ; de Theije CC; Snepvangers FJ; Kelders MC; Ubags ND; Haegens A; Langen RC
    Biochim Biophys Acta; 2015 Mar; 1852(3):490-506. PubMed ID: 25496993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I inhibits dexamethasone-induced proteolysis in cultured L6 myotubes through PI3K/Akt/GSK-3beta and PI3K/Akt/mTOR-dependent mechanisms.
    Li BG; Hasselgren PO; Fang CH
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2207-16. PubMed ID: 15927518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of glycogen synthase kinase 3β (GSK-3β) enhances mitochondrial biogenesis during myogenesis.
    Theeuwes WF; Gosker HR; Langen RCJ; Pansters NAM; Schols AMWJ; Remels AHV
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2913-2926. PubMed ID: 29883716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and wnt1 pathways cooperate to induce reserve cell activation in differentiation and myotube hypertrophy.
    Rochat A; Fernandez A; Vandromme M; Molès JP; Bouschet T; Carnac G; Lamb NJ
    Mol Biol Cell; 2004 Oct; 15(10):4544-55. PubMed ID: 15282335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of 14-3-3zeta as an adapter for IGF-1 and Akt/GSK-3beta signaling and survival of renal mesangial cells.
    Singh LP; Jiang Y; Cheng DW
    Int J Biol Sci; 2006 Oct; 3(1):27-39. PubMed ID: 17200689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-I does not prevent myotube atrophy caused by proinflammatory cytokines despite activation of Akt/Foxo and GSK-3beta pathways and inhibition of atrogin-1 mRNA.
    Dehoux M; Gobier C; Lause P; Bertrand L; Ketelslegers JM; Thissen JP
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E145-50. PubMed ID: 16926385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-I activates the mouse type IIb myosin heavy chain gene.
    Shanely RA; Zwetsloot KA; Childs TE; Lees SJ; Tsika RW; Booth FW
    Am J Physiol Cell Physiol; 2009 Oct; 297(4):C1019-27. PubMed ID: 19657059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin impairs myogenesis in C2C12 cells through JAK/STAT and MEK signaling pathways.
    Pijet M; Pijet B; Litwiniuk A; Pajak B; Gajkowska B; Orzechowski A
    Cytokine; 2013 Feb; 61(2):445-54. PubMed ID: 23201486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
    Deng H; Dokshin GA; Lei J; Goldsmith AM; Bitar KN; Fingar DC; Hershenson MB; Bentley JK
    J Biol Chem; 2008 Apr; 283(15):10198-207. PubMed ID: 18252708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.